Company Overview of Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. develops therapies for the treatment of neuro-inflammatory diseases. The company offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded in 2009 and is based in San Francisco, California.
30 Hill Street
San Francisco, CA 94110
Founded in 2009
Key Executives for Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|CCS Associates, Inc.||United States|
|Neurogen Corp.||United States|
|Metrics, Inc.||United States|
|Eckert & Ziegler Vitalea Science, Inc.||United States|
|Cellco, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Huntingdon County, PA | AstraZenecaPosted: Mar 14
- Philadelphia, PA | PwCPosted: Apr 09
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
Sponsored Financial Commentaries
To contact Xalud Therapeutics, Inc., please visit www.xaludthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.